Your preferred CRO for Drug and Device Studies
CMX has the proficiency to conduct your clinical trial with Qualified Investigators in Canada .
Urology • Oncology • Immunology • Cardiology • Dermatology • Endocrinology • Respirology • Medical Devices
Superior project management at CMX encompasses timely ethics submissions, study start-up, budget and contract negotiation, enrollment & patient recruitment, study metrics, eDC, data query management, advertising campaigns and study close-out.
Full Service Contract Research Organization (CRO)
CMX understands the importance and complexity of Phase I-IV clinical trials. Since 1992, we have completed over 400 studies successfully and continue to serve clients globally.
CMX Research Inc. has an extensive network of clinical trial sites across Canada and the USA .We can manage your Phase I-IV trial with the ability to run trials across multiple disciplines.
CMX has highly qualified CRAs that ensure compliance with your drug or device study. Phase I – IV as well as BA/BE studies are monitored according to ICH GCP.
Why Choose us?
CMX Research Inc. has a team that understands what it takes to develop and successfully implement solutions to achieve your study objectives. CMX has a proven track record of managing clinical trials from drug development to post marketing. Our results-focused CRO is ready to work with your team. Our specialties are: urology, oncology, immunology, cardiology, dermatology, endocrinology, and respirology studies. We can help your organization in other indications as well as device trials.
Our CEO is a practicing urologist and principal investigator who thoroughly understands the challenges associated with clinical trials.
When you choose CMX you can be confident that you will have access to:
Largest Urology-Oncology Network in Canada and USA
Proactive Project Planning and Implementation
Faster Recruitment Times
Customized services that are cost and time effective
Unlimited Support from Start to Finish
Over 32 years of Experience
Access to Principal Investigators in all Medical Indications
Thank You for visiting the CMX website. After 34 years in clinical research, 26 of those as a principal investigator, I have led the CMX team in designing and executing over 425 Phase I-IV clinical trials. At CMX, we offer numerous tailor-made services to fit your needs. Allow CMX to contribute to your organization’s success.
Richard Casey, MD, FRCS(C)
C.E.O. and Medical Director
CMX Research Inc. works with an elite portfolio of clients, ranging from domestic and large global pharmaceutical organizations to emerging Biotech firms and device companies. Our extensive network allows us to provide services to companies around the globe.
Let CMX Research Inc. plan and implement your Clinical Development Programs. Please fill in the form below or call us at 1-877-290-0018.